FDA Adverse Event Malfunction Summary report: N

OMNIPOD 5 POD

MDR report key: 15048903 · Received July 18, 2022

Report

Report Number
3004464228-2022-12225
Event Type
Malfunction
Date Received
July 18, 2022
Date of Event
July 9, 2022
Report Date
July 11, 2022
Manufacturer
INSULET CORPORATION
Product Code
QFG
UDI-DI
10385083000114
PMA / PMN Number
K203768
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

ACCORDING TO THE COMPLAINANT THE DEVICE WILL NOT BE RETURNED FOR INVESTIGATION. IT WAS REPORTED THE CANNULA WAS POSSIBLY NOT INSERTED CORRECTLY INTO THE INFUSION SITE. THIS CONDITION COULD INTERRUPT INSULIN DELIVERY AND CONTRIBUTE TO HYPERGLYCEMIA. NO LOT RELEASE RECORDS WERE REVIEWED, AS THE PRODUCT LOT NUMBER WAS NOT PROVIDED.

Additional Manufacturer Narrative · 0

CORRECTION TO D(4): MODEL NO CHANGED FROM PT-000536 TO PT-000435. CATALOG NO CHANGED FROM UNAVAILABLE TO POD-BLE-H1-520. UNIQUE IDENTIFIER (UDI) # CHANGED TO (B)(4).

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT'S BLOOD GLUCOSE (BG) LEVELS REACHED OVER 400 MG/DL WHILE WEARING THE POD BETWEEN 4 AND 24 HOURS. DUE TO ELEVATED BG LEVELS, PATIENT WAS UNSURE IF CANNULA HAD PROPERLY INSERTED IN THE INFUSION SITE (ARM).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
261180 OMNIPOD 5 POD ALTERNATE CONTROLLER ENABLED INSULIN INFUSION PUMP QFG INSULET CORPORATION PT-000435 PP1K02072231 10385083000114

Patients

Seq Age Sex Outcome Treatment
1 5 YR Male